Barriers to prescribing glucose-lowering therapies with cardiometabolic benefits
Yumin Gao(Johns Hopkins University), Neha J. Pagidipati(Duke University), Eric D. Peterson(The University of Texas Southwestern Medical Center)
Cited by 74
Related Papers
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
|Circulation|2011|1.8k
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
|Journal of the American College of Cardiology|2011|914